These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 25889239

  • 1. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X, Zhu Y, Kang H, Zhang Y, Liang H, Wang S, Zhang W.
    Cancer Imaging; 2015 Mar 21; 15(1):4. PubMed ID: 25889239
    [Abstract] [Full Text] [Related]

  • 2. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ, Lu SS, Han QY, Zhou MD, Hong XN.
    Acta Radiol; 2019 Jun 21; 60(6):777-787. PubMed ID: 30244590
    [Abstract] [Full Text] [Related]

  • 3. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J, Gupta PK, Sahoo P, Singh A, Patir R, Ahlawat S, Beniwal M, Thennarasu K, Santosh V, Gupta RK.
    Neuroradiology; 2018 Jan 21; 60(1):43-50. PubMed ID: 29090331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade.
    Jia ZZ, Geng DY, Liu Y, Chen XR, Zhang J.
    Chin Med J (Engl); 2013 Jan 21; 126(10):1953-6. PubMed ID: 23673117
    [Abstract] [Full Text] [Related]

  • 6. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
    Jia ZZ, Gu HM, Zhou XJ, Shi JL, Li MD, Zhou GF, Wu XH.
    Eur J Radiol; 2015 Sep 21; 84(9):1805-9. PubMed ID: 26066470
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N.
    Eur J Radiol; 2016 Jun 21; 85(6):1147-56. PubMed ID: 27161065
    [Abstract] [Full Text] [Related]

  • 10. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
    Jiang JS, Hua Y, Zhou XJ, Shen DD, Shi JL, Ge M, Geng QN, Jia ZZ.
    Acad Radiol; 2019 Sep 21; 26(9):1215-1221. PubMed ID: 30416002
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY, Ahn KJ, Lee YS, Jang JH, Jung SL, Kim BS.
    Acta Radiol; 2018 Jun 21; 59(6):723-731. PubMed ID: 28862024
    [Abstract] [Full Text] [Related]

  • 12. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J, Peck KK, Young RJ, Holodny AI, Karimi S, Lyo JK.
    J Neuroimaging; 2015 Jun 21; 25(5):792-8. PubMed ID: 25867683
    [Abstract] [Full Text] [Related]

  • 13. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY.
    AJNR Am J Neuroradiol; 2009 Aug 21; 30(7):1402-8. PubMed ID: 19369602
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
    Hu Y, Zhang N, Yu MH, Zhou XJ, Ge M, Shen DD, Hua Y, Shi JL, Jia ZZ.
    Eur J Radiol; 2020 Oct 21; 131():109247. PubMed ID: 32891974
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC, Watkins TW, Kwan GN, Haacke EM.
    J Neuroimaging; 2016 Jul 21; 26(4):383-90. PubMed ID: 27227542
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC.
    Magn Reson Imaging; 2008 Nov 21; 26(9):1279-93. PubMed ID: 18487033
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.